Skip to main content
SpringerLink
Log in

Newer antibiotics

  • Symposium: Advances in Therapy
  • Published:
The Indian Journal of Pediatrics Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Chang TW, Weinstein L: Morphological changes in Gram-negative bacilli exposed to cephalothin. J Bacter 88: 1790, 1964

    CAS  Google Scholar 

  2. Neu HC: Comparison of the pharmacokinetics of cefamandole and other cephalosporin compounds. J Infect Dis 137: S 80, 1978

    CAS  Google Scholar 

  3. Waterman NG, Eickenberg HU, Scharfenberger L: Concentration of cefamandole in serum interstitial fluid, bile, and urine. Antimicrob Agents Chemother 10:733, 1976

    PubMed  CAS  Google Scholar 

  4. Thirumoorthi MC, Dajani AS, Vincent CV, Maurer MJ: Pharmacology, safety, and efficacy of cefamandole in childhood infections. Antimicrob Agents Chemother 20:21, 1981

    PubMed  CAS  Google Scholar 

  5. Stapley EO, Birnbaum J, Miller AK, Wallick H, Hendlin D, Woodruff HB: Cefoxitin and cephamycins: Microbiological studies. Rev Infect Dis 1: 73, 1979

    PubMed  CAS  Google Scholar 

  6. Santos JI, Jacobson JA, Swensen P, Palmer WM: Cellulitis: treatment with cefoxitln compared with multiple antibiotic therapy. Pediatrics 67: 887, 1981

    PubMed  CAS  Google Scholar 

  7. McCracken GH, Ginsburg CM, Clahsen JC, Thomas ML: Pharmacokinetics of cefaclor in infants and children. J Antimicrob Chemother 4: 515, 1978

    Article  PubMed  CAS  Google Scholar 

  8. Ginsburg CM, McCracken GH: Cefaclor and cefadroxil: A commentary on their properties and possible indications for use in pediatrics. J Pediatr 96: 340, 1980

    Article  PubMed  CAS  Google Scholar 

  9. Nelson JD, Ginsburg CM, Clahsen JC, Jackson LH: Treatment of acute otitis media of infancy with cefaclor. Am J Dis Child 132: 992, 1978

    PubMed  CAS  Google Scholar 

  10. Ginsbury CM, McCracken GH Clahsen JC, Thomas ML: Clinical pharmacology of cefadroxil in infants and children. Antimicrob Agents Chemother 13: 845, 1978

    Google Scholar 

  11. Sosna JP, Murray PR, Medoff G: Comparison of the in vitro activities of HR 756 with cephalothin, cefoxitin, and cefamandole. Antimicrob Agents Chemother 14: 876, 1978

    PubMed  CAS  Google Scholar 

  12. Clumeck N, Vanlaethem Y, Butzler JP: Therapeutic effectiveness and pharmacokinetic results of cefotaxime (HR-756) in human infections due to multiresistant bacteria,In, Current Chamotherapy, Proceedings of the 11th International Congress of Chemotherapy, American Society for Microbiology, Washington, D.C. 1980 p. 122

  13. Helwing HF: Cefotaxime in pediatrics,In, Current Chemotherapy, Proc 11th Internat Congr Chemother, 1980, p. 128

  14. Kafetzis DA, Kanarios J, Sinaniotis CA, Papadatos CJ: Clinical and pharmacokinetic study of cefotaxime (HR-756) in infants and children,In, Current Current Chemotherapy, Proc 11th Internat Congr Chemother, 1980, p. 134

  15. Belohradsky BH, Bruch K, Geiss D, Kafetzis D, Marget W, Peters G: Intravenous cefotaxime in children with bacterial meningitis. Lancet 1: 61, 1980

    Article  PubMed  CAS  Google Scholar 

  16. Wise R, Andrews JM, Beford KA: LY 127935 a novel oxa-B-lactam: An in vitro comparison with other B-lactam antibioties. Antimicrob Agents Chemother 16: 341, 1979

    PubMed  CAS  Google Scholar 

  17. Hall WH, Opfer BJ, Gerding DN: Comparative activities of the oxabeta-lactam LY 127935, cefotaxime, cefoperazone, cefamandole, and ticarcillin against multiply resistant gram-negative bacilli. Antimicrob Agents Chemother 17: 273, 1980

    PubMed  CAS  Google Scholar 

  18. Kaplan SL, Mason EO, Garcia H, Kvernland SJ, Loiselle EM, Anderson DC, Mintz AA, Feigin RD: Pharmacokinetics and cerebrospinal fluid penetration of moxalactam in children with bacterial meningitis. J Pediatr 98: 152, 1981

    Article  PubMed  CAS  Google Scholar 

  19. Schaad UB, McCracken GH, Threlkeld N, Thomas ML: Clinical evaluation of a new broad-spectrum oxa-beta-lactam antibiotic, moxalactam, in neonates and infants. J Pediatr 98: 129, 1981

    Article  PubMed  CAS  Google Scholar 

  20. Kumar A, Aziz MT: Moxalactam in treatment of recurrentEscherichia coli meningitis and ventriculitis in an infant with agammaglobulinemia. Drug Intell Clin Pharm 15: 50, 1981

    PubMed  CAS  Google Scholar 

  21. Matsumoto K. Uzuka Y, Nagatake T, Shishido H: Clinical evaluation of 6059-S, a new action oxacephem.In, Current Chemotherapy, Proc 11th Internat Congr Chemother, 1980, p 112

  22. Jones RN, Fuchs PC, Barry AL, Gavan TL, Sommers HM, Gerlach EH: In vitro evaluation of cefoperazone (T-1551) a new semisynthetic cephalosporin: Six-center Collaborative Study.In, Current Chemotherapy, Proc 11th Internat Congr Chemother, 1980, p. 179

  23. Aoki N, Sekine O, Usuda Y, Shimizu T, Hirasawa Y, Aoki T: Serum, urine, and bile levels of ceforazone (T-1551),In, Current Chemotherapy, Proc 11th Internat Congr Chemother, 1980, p 159

  24. Ueda Y, Saito A, Ohmori M, Siba K: Clinical studies on cefoperazone (T-1551) in the field of internal medicine,In, Current Chemotherapy, Proc 11th Internat Congr Chemother, 1980, p 165

  25. Matsuda S, Tanno M, Kashiwagura T, Furuya H: Placental transfer of cefoperazone (T-1551) and a clinical study of its use in obstetrics and gynecological infections,In, Current Chemotherapy, Proc 11th Internat Congr Chemother, 1980, p. 167

  26. Kumin GD: Clinical nephrotoxicity of tobramycin and gentamicin. A prospective study. JAMA 244: 1808, 1980

    Article  PubMed  CAS  Google Scholar 

  27. Smith CR, Lipsky JJ, Laskin OL, Hellmann DB, Mellits ED, Longstreth J, Lietman PS: Double-blind comparison of the nephrotoxicity and auditory toxicity of gentamicin and tobramycin. N Engl J Med 302: 1106, 1980

    Article  PubMed  CAS  Google Scholar 

  28. McCracken GH, Nelson JD: Antimicrobial therapy for Newborns, Chapter 2 Clinical pharmacology and dosage, p. 5, Grune and Stratton, Inc., 1977

  29. Kaiser AB, McGee ZA: Aminoglycoside therapy of Gram-negative bacillary meningitis. N Engl J Med 293: 1215, 1975

    Article  PubMed  CAS  Google Scholar 

  30. Vogelstein B, Kowarski AA, Lietman PS: The pharmacokinetics of amikacin in children. J Pediatr 91: 333, 1977

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Pediatric Infectious Diseases, Saint Luke’s Hospital, 11311 Shaker Blvd, 44104, Cleveland, Ohio, USA

    Ashir Kumar M.B., B.S., M.D.

Authors
  1. Ashir Kumar M.B., B.S., M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kumar, A. Newer antibiotics. Indian J Pediatr 48, 617–626 (1981). https://doi.org/10.1007/BF02821589

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02821589

Keywords

Search

Navigation